InsiderClue
← All stocks

Indaptus Therapeutics, Inc.

INDP Net buying
CIK 0001857044 #3996 in the set updated 22 Sep 2026
Bought (120 mo)
$492.87K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$100.04K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$100.04K
2 of 2 sales
Net
+$392.83K
+$392.83K against sales at will

By person

7 insiders · 18 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Meckler Jeffrey A
Co-Chief Executive Officer
$273.57K (8)
—
+$273.57K
229,929
$538.03K
—
Anderson Glen R.
10% owner
$216.39K (3)
—
+$216.39K
1,190,400
$2.79M
+9.5%
Newman Michael James
CSO and Director
—
$100.04K (2)
−$100.04K
1,469,430
$3.44M
+2.2%
Litchev Boyan Vesselinov
Chief Medical Officer
$2.52K (4)
—
+$2.52K
1,150
$2.69K
—
Linscott Walt Addison
Chief Operating Officer
$393.00 (1)
—
+$393.00
54,426
$127.36K
—
Sassi Nir
Chief Financial Officer
—
—
—
26,758
$62.61K
—
Ben-Tzvi Avraham
Director
—
—
—
25,100
$58.73K
+25,000%

No percentages here. This company's share count has moved by a factor of 120.4 over the window, from 1,106,529 to 133,242,324 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
Anderson Glen R.
14 Aug 2023
10% owner
Buy indirect
23,934
$2.34
$56.01K
Anderson Glen R.
11 Aug 2023
10% owner
Buy indirect
35,064
$2.12
$74.34K
Anderson Glen R.
10 Aug 2023
10% owner
Buy indirect
44,354
$1.94
$86.05K
Litchev Boyan Vesselinov
1 Dec 2022
Chief Medical Officer
Buy
500
$1.87
$935.45
Litchev Boyan Vesselinov
22 Nov 2022
Chief Medical Officer
Buy
500
$1.83
$915.00
Meckler Jeffrey A
21 Nov 2022
CEO and Director
Buy
9,600
$1.90
$18.24K
Meckler Jeffrey A
18 Nov 2022
CEO and Director
Buy
400
$1.76
$705.48
Meckler Jeffrey A
8 Sep 2022
CEO and Director
Buy
10,308
$2.80
$28.86K
Meckler Jeffrey A
7 Sep 2022
CEO and Director
Buy
8,632
$2.57
$22.18K
Linscott Walt Addison
7 Sep 2022
Chief Business Officer
Buy
150
$2.62
$393.00
Meckler Jeffrey A
6 Sep 2022
CEO and Director
Buy
1,060
$2.44
$2.59K
Meckler Jeffrey A
6 Jun 2022
CEO and Director
Buy
19,727
$2.63
$51.88K
Litchev Boyan Vesselinov
2 Mar 2022
Chief Medical Officer
Buy
50
$4.09
$204.63
Litchev Boyan Vesselinov
31 Jan 2022
Chief Medical Officer
Buy
100
$4.65
$465.00
Meckler Jeffrey A
18 Nov 2021
CEO and Director
Buy
11,187
$5.82
$65.11K
Meckler Jeffrey A
14 Sep 2021
CEO and Director
Buy
12,000
$7.00
$84.00K
Show all 18 transactions →

What was left out

Form 4 filings counted 84
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 508,553
Sales filed before the plan box existed 2
History held since 6 Aug 2021